Prakash Vishnu

Associate Professor

University of Washington

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (4)

Damon Houghton

Associate Professor Of Medicine

Mayo Clinic

UNITED STATES

View details

Henning Nilius

University of Bern

SWITZERLAND

View details

Yoshiaki Tomiyama

Prof.

Osaka University Hospital

JAPAN

View details

Jens Peter Goetze

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Prakash Vishnu

Research Interests

Explore related searches

Contact this professor

Articles (10)

Accuracy of Diagnosing Heparin-Induced Thrombocytopenia

A machine-learning model for reducing misdiagnosis in heparin-induced thrombocytopenia: a prospective, multicenter, observational study

Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT study

Associations of Cutaneous Immune-Related Adverse Effects of Immunotherapy With Treatment Response in Patients With Metastatic Melanoma

COVID-19 vaccination associated severe immune thrombocytopenia

Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors

Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial

International Survey on Helicobacter Pylori Testing in Patients with Immune Thrombocytopenia: Communication of the Platelet Immunology Scientific and Standardization Committee.

Elevated Neutrophil-Lymphocyte Ratio is Predictive of Poor Outcomes Following Aneurysmal Subarachnoid Hemorrhage

Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial

Collaborators (4)

Damon Houghton

Henning Nilius

Yoshiaki Tomiyama

Jens Peter Goetze

Make your next move.